About Srinija
Srinija is a Chemicals & Materials company based in Vijayawada (India) founded in 2000. It provides custom synthesis, process development, and manufacturing services for specialized needs. It operates on a B2B model. The company has 19 employees. Its Indian entity Srinija Drugs Private Limited reported revenue of ₹19.09 Cr. Its focus areas include Manufacturing, Chemical Manufacturing, Custom Synthesis and Process Development. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Srinija, based in Vijayawada, focuses on producing manufactured goods, chemical manufacturing, custom synthesis, and process development. Provides custom synthesis, process development, and manufacturing services for specialized needs. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Vijayawada, India
- Employees 19
- SectorsChemicals & Materials
- Website srinija.com
- Legal Name Srinija Drugs Private Limited
- Date of Incorporation 17 Apr, 2000
- Jurisdiction Andhra Pradesh, India
- Annual Revenue₹19.09 Cr
FY 2024 · +64% YoY
- Net Profit₹94.6 Lakh
FY 2024 · 5% margin
- EBITDA₹2.31 Cr
FY 2024 · 12% margin
- Employee Count19
Associated legal entities of Srinija
Srinija operates through Srinija Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srinija Drugs Private Limited CIN U24233AP2000PTC034263 | Active | 17 Apr 2000 | ₹19.1 Cr | 19 | 6 | View details |
Board of directors of Srinija Drugs Private Limited (Srinija)
Srinija Drugs Private Limited is the primary company behind Srinija. The board of Srinija Drugs Private Limited currently have 6 directors; the longest-serving is Laxmanarao Talluri, appointed in 2000.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Laxmanarao Talluri DIN 01746373 | Director | 17 Apr 2000 | 26 yrs 6 mo | Srinija Drugs Private Limited |
| Venkata Ramesh Donavalli DIN 01746408 | Director | 17 Apr 2000 | 26 yrs 6 mo | Srinija Drugs Private Limited |
| Bulli Raju Nekkanti DIN 01746430 | Managing Director | 17 Apr 2000 | 26 yrs 6 mo | Srinija Drugs Private Limited |
| Nekkanti Saraswathi DIN 07684289 | Director | 28 Oct 2023 | 3 yrs | Srinija Drugs Private Limited |
| Venkata Satyavani Donavalli DIN 07690103 | Director | 28 Oct 2023 | 3 yrs | Srinija Drugs Private Limited |
| Anantha Laxmi Talluri DIN 07690076 | Director | 28 Oct 2023 | 3 yrs | Srinija Drugs Private Limited |
Financials of Srinija
Figures of Srinija Drugs Private Limited, the primary company behind Srinija, for FY 2024. Revenue was ₹19.09 Cr (+64% year on year). Net profit was ₹94.6 Lakh (5% margin). EBITDA was ₹2.31 Cr (12% margin). Revenue has grown at a compounded annual rate of +16% over three years and +15% over five years.
- ₹19.09 CrRevenue · FY 2024 · +64% YoY
- ₹94.6 LakhNet profit · 5% margin
- ₹2.31 CrEBITDA · 12% margin
- ₹60 LakhPaid-up capital
- 19Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Srinija Drugs Private Limited are on its company page.
Detailed financial statements for Srinija
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Srinija
Srinija has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Srinija
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Chemical Services
2 companies that operate in the same segment as Srinija (Chemical Services) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Specialty chemical manufacturing, research, and services across multiple industries. | 2023 | Bengaluru, Karnataka, India | USD 2.13 M | |||
PVC and plastic products are manufactured and traded. | 2021 | Delhi, Delhi, India | USD 53.18 M | 6 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Srinija
Srinija was founded in 2000.
Srinija is headquartered in Vijayawada, India. It is registered at Vijayawada, Andhra Pradesh, India.
Srinija has 19 employees.
The primary company behind Srinija, Srinija Drugs Private Limited, reported revenue of ₹19.09 Cr for FY 2024, up 64% year on year.
Srinija, based in Vijayawada, focuses on producing manufactured goods, chemical manufacturing, custom synthesis, and process development. Provides custom synthesis, process development, and manufacturing services for specialized needs. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Srinija's top competitors include Laurus Labs, Symbiotec and SeQuent.
Srinija operates through Srinija Drugs Private Limited.
The legal entities of Srinija currently have 6 directors, including Nekkanti Saraswathi, Venkata Satyavani Donavalli, Anantha Laxmi Talluri and others.